• Explore /
  • Poster
  • / TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma.

TACTICAL: A phase I/II trial to assess the safety and efficacy of MSCTRAIL in the treatment of metastatic lung adenocarcinoma.

Abstract Poster

Authors

null

Alice Davies

Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom

Alice Davies , Beth Sage , Krishna Kolluri , Doraid Alrifai , Rebecca Graham , Ben Weil , Rita Rego , Owen Bain , P. Stephen Patrick , Kim Champion , Alex Day , Bilyana Popova , Graham Wheeler , Dan Fullen , Tammy Kalbur , Martin Forster , Mark Lowdell , Sam Janes

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT03298763

Citation

J Clin Oncol 37, 2019 (suppl; abstr TPS9116)

DOI

10.1200/JCO.2019.37.15_suppl.TPS9116

Abstract #

TPS9116

Poster Bd #

438a

Abstract Disclosures

Similar Posters

First Author: Martin Reck

First Author: Marina Chiara Garassino

First Author: Christian Grohé

First Author: Makoto Nishio